- Home
- GNE vs ATAI Comparison
GNE vs ATAI Comparison
Compare GNE & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNE
- ATAI
- Stock Information
- Founded
- GNE 2011
- ATAI 2018
- Country
- GNE United States
- ATAI Germany
- Employees
- GNE N/A
- ATAI N/A
- Industry
- GNE Power Generation
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- GNE Utilities
- ATAI Health Care
- Exchange
- GNE Nasdaq
- ATAI Nasdaq
- Market Cap
- GNE 413.5M
- ATAI 444.7M
- IPO Year
- GNE N/A
- ATAI 2021
- Fundamental
- Price
- GNE $15.69
- ATAI $4.57
- Analyst Decision
- GNE
- ATAI Strong Buy
- Analyst Count
- GNE 0
- ATAI 3
- Target Price
- GNE N/A
- ATAI $13.33
- AVG Volume (30 Days)
- GNE 226.5K
- ATAI 6.3M
- Earning Date
- GNE 08-07-2025
- ATAI 08-14-2025
- Dividend Yield
- GNE 1.97%
- ATAI N/A
- EPS Growth
- GNE 4.51
- ATAI N/A
- EPS
- GNE 0.31
- ATAI N/A
- Revenue
- GNE $456,876,000.00
- ATAI $2,309,000.00
- Revenue This Year
- GNE $14.60
- ATAI $423.05
- Revenue Next Year
- GNE $8.64
- ATAI N/A
- P/E Ratio
- GNE $39.05
- ATAI N/A
- Revenue Growth
- GNE 3.75
- ATAI 510.85
- 52 Week Low
- GNE $13.05
- ATAI $1.03
- 52 Week High
- GNE $28.47
- ATAI $4.74
- Technical
- Relative Strength Index (RSI)
- GNE 27.83
- ATAI 70.54
- Support Level
- GNE $15.19
- ATAI $3.60
- Resistance Level
- GNE $16.60
- ATAI $4.23
- Average True Range (ATR)
- GNE 0.82
- ATAI 0.33
- MACD
- GNE -0.03
- ATAI -0.01
- Stochastic Oscillator
- GNE 8.71
- ATAI 85.09
About GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.